0001557939-15-000043.txt : 20150729 0001557939-15-000043.hdr.sgml : 20150729 20150729090240 ACCESSION NUMBER: 0001557939-15-000043 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20150729 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150729 DATE AS OF CHANGE: 20150729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acelity L.P. Inc. CENTRAL INDEX KEY: 0001557939 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 981022387 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-184233-14 FILM NUMBER: 151011300 BUSINESS ADDRESS: STREET 1: 12930 IH 10 WEST CITY: SAN ANTONIO STATE: TX ZIP: 78249 BUSINESS PHONE: 2102556898 MAIL ADDRESS: STREET 1: 12930 IH 10 WEST CITY: SAN ANTONIO STATE: TX ZIP: 78249 FORMER COMPANY: FORMER CONFORMED NAME: Centaur Guernsey L.P. Inc. DATE OF NAME CHANGE: 20120911 8-K 1 a2015q28-kearningsrelease.htm 8-K 2015 Q2 8-K Earnings Release


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 29, 2015


ACELITY L.P. INC.
(Exact name of registrant as specified in its charter)

Guernsey
 
333-184233-14
 
98-1022387
(State or other jurisdiction of incorporation or organization)
 
Commission File Number
 
(I.R.S. Employer Identification No.)

12930 West Interstate 10
San Antonio, Texas 78249
(Address of principal executive offices)

Registrant's telephone number, including area code: (210) 524-9000

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))







Item 2.02. Results of Operations and Financial Condition
Acelity L.P. Inc. is reporting its financial results for the three and six months ended June 30, 2015. The report is attached hereto and incorporated herein by reference.
The information in this Item, including Exhibit 99.1, is being furnished, not filed. Accordingly, the information set forth in this Item will not be incorporated by reference into any registration statement filed by Acelity L.P. Inc., under the Securities Act of 1933, as amended, unless specifically identified therein as being incorporated therein by reference.

Item 9.01. Financial Statements and Exhibits
(d) Exhibits
The following exhibits are filed with this Form 8-K:
Exhibit No.
 
Description
99.1
 
Acelity L.P. Inc. Second Quarter and First Half Financial Results for 2015









SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
ACELITY L.P. INC.
(REGISTRANT)
 
 
 
 
Date: July 29, 2015
 
By:
/s/ Brian Busenlehner
 
 
Name:
Brian Busenlehner
 
 
Title:
Authorized Signatory





EXHIBIT INDEX
Exhibit No.
 
Description
99.1
 
Acelity L.P. Inc. Second Quarter and First Half Financial Results for 2015





 EX-99.1 2 a9912015q2earningsrelease.htm EXHIBIT 99.1 SECOND QUARTER AND FIRST HALF FINANCIAL RESULTS FOR 2015 99.1 2015 Q2 Earnings Release



ACELITY L.P. INC. REPORTS
SECOND QUARTER AND FIRST HALF FINANCIAL RESULTS FOR 2015
U.S. Advanced Wound Therapeutics revenue grew 10%


Second Quarter Financial Highlights

•
Revenue of $461.6 million, up 0.5% from the prior-year period and 5.1% on a constant currency basis

•
Revenue from Advanced Wound Therapeutics (“AWT”) devices grew double digits in the U.S. led by double digit volume increases compared to the prior-year period

•
Loss from continuing operations improved to $17.6 million compared to $153.8 million in the prior-year period

•
Adjusted EBITDA from continuing operations1 of $172.9 million, grew 2.9% versus the prior-year period and 5.6% on a constant currency basis, achieving an Adjusted EBITDA margin of 37.5%


Operational Highlights

•
Acelity’s revolutionary V.A.C.® Therapy technology achieves another record level of seasonally adjusted worldwide rental volumes

•
Announced two innovative product offerings in Europe: TIELLE® Non Adhesive, intended to manage a range of exudate levels and increase the comfort and ease for a patient; and the REVOLVE™ System which offers fast, efficient and secure fat tissue processing in a range of reconstructive procedures


Joe Woody, President and Chief Executive Officer, commented, “We delivered a strong financial performance in the second quarter, reflecting the power of Acelity’s growing global scale, innovative product portfolio and robust sales and service infrastructure. 

“On a consolidated basis, we delivered another consecutive quarter of year over year revenue growth. We have extended our leading position in North America and have also generated strong growth in emerging markets with double-digit increases across Latin America, China and India. In addition, we successfully introduced new products including Nanova™, TIELLE® and REVOLVE™ as well as negotiated future sales channels and distributors.

“Looking ahead, we believe we have the right strategies in place to ensure a resilient platform for sustainable growth. We continue to invest in innovation, further penetration within emerging markets, and development of markets served by our focus products in order to generate long-term value creation.”







Results of the second quarter and six months ended June 30, 2015

Acelity revenue for the second quarter of 2015 was $461.6 million, up from the prior-year period by 0.5% as reported and 5.1% on a constant currency basis.

•
AWT revenue was $354.2 million, up 1.9% as reported and 7.4% on a constant currency basis, compared to the prior-year period. Growth in AWT revenue was driven by increased NPWT volumes, continued strength in focus product growth led by sales of Prevena™, and sustained growth in our international markets resulting from increased global market penetration.

•
Regenerative Medicine revenue was $103.5 million, down 3.7% as reported and 2.3% on a constant currency basis, compared to the prior-year period. The decline was primarily due to lower volumes associated with U.S. hernia repair procedures, partially offset by strong growth in international markets.

Adjusted EBITDA from continuing operations for the second quarter of 2015 increased 2.9% to $172.9 million from $167.9 million in the prior-year period and increased 5.6% on a constant currency basis. The growth rate of Adjusted EBITDA from continuing operations was negatively impacted by 2.7% due to unfavorable movements in foreign exchange rates. Growth in Adjusted EBITDA was primarily attributable to strong revenue coupled with lower expenses resulting from our integration and business optimization efforts. Our loss from continuing operations for the second quarter of 2015 was $17.6 million, compared to $153.8 million in the prior-year period.

Acelity revenue for the six months ended June 30, 2015 was $905.7 million, up from the prior-year period by 0.4% as reported and 4.7% on a constant currency basis.

•
AWT revenue was $691.5 million, up 1.9% as reported and 7.1% on a constant currency basis, compared to the prior-year period. Growth in AWT revenue was fueled primarily by higher NPWT volumes during the first half of 2015, double-digit focus product growth, and growth in our international markets.

•
Regenerative Medicine revenue was $207.7 million, down 3.0% as reported and 1.7% on a constant currency basis, compared to the prior-year period. The decline was primarily due to lower volumes associated with U.S. hernia repair procedures, partially offset by growth in breast reconstruction and solid growth in international markets.

Adjusted EBITDA from continuing operations for the six months ended June 30, 2015 increased 5.2% to $338.7 million from $322.0 million in the prior-year period and increased 8.0% on a constant currency basis. The growth rate of Adjusted EBITDA from continuing operations was negatively impacted by 2.8% due to unfavorable movements in foreign exchange rates. Growth in Adjusted EBITDA was primarily attributable to solid revenue performance as well as expense savings associated with integration and business optimization efforts. Our loss from continuing operations for the six months ended June 30, 2015 was $22.2 million, compared to $200.9 million in the prior-year period.


Financial Position

Total cash at June 30, 2015 was $141.2 million. During the first six months of 2015, Acelity used cash of $5.3 million in operations, used cash of $39.0 million in investing activities and provided cash of $7.0 million from financing activities.

As of June 30, 2015, total long-term debt outstanding, net of discounts, was $4.837 billion and our Net Leverage Ratio2 was 6.3x.


Company Structure

Acelity is a non-operating holding company whose business is comprised of the operations of wholly-owned subsidiaries that commercialize our advanced wound therapeutics and regenerative medicine products. Our advanced wound therapeutics business is conducted by KCI and its subsidiaries, including Systagenix, and our regenerative medicine business is conducted by LifeCell. Acelity is controlled by investment funds advised by Apax Partners and controlled affiliates of Canada Pension Plan Investment Board and the Public Sector Pension Investment Board and certain other co-investors.  Unless otherwise noted in this report, the terms “we,” “our” or “Company,” refer to Acelity and its subsidiaries, collectively.





Non-GAAP Financial Information

The following provides information regarding non-GAAP financial measures used in this earnings release:

To supplement our consolidated results presented in accordance with accounting principles generally accepted in the United States (“GAAP”), we have disclosed non-GAAP financial measures of operating results that exclude or adjust certain items. A reconciliation of Adjusted EBITDA from continuing operations and Adjusted EBITDA to net loss is provided later in this earnings release. In addition, the Company presents certain of its financial results on a constant currency basis in addition to GAAP results. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. In this release, we calculate constant currency by calculating current-year results using prior-year foreign currency exchange rates.

Management believes these non-GAAP financial measures provide useful supplemental information for its and investors' evaluation of our business performance and are useful for period-over-period comparisons of the performance of our business. While management believes that these financial measures are useful in evaluating our business, this information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similarly entitled measures reported by other companies. See "Reconciliation from GAAP to Non-GAAP" included within this release for a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures.



1Adjusted EBITDA from continuing operations excludes the operations of our previously divested SPY ELITE® business and the impact of merger-related expenses, foreign currency gains or losses, business optimization expenses and other expenses specified in the reconciliation within this release.

2 The Net Leverage Ratio represents Net Debt divided by Consolidated EBITDA for the last twelve months. Net Debt consists of total indebtedness including capital leases and other financing obligations, less cash and cash equivalents up to the greater of$300.0 million or 40% of Consolidated EBITDA for the last twelve months. Consolidated EBITDA, as defined in our senior secured credit agreement, represents Adjusted EBITDA from continuing operations plus “run rate” cost savings.


FOR MORE INFORMATION, CONTACT:
Investors
Caleb Moore
Office: (210) 255-6433
caleb.moore@acelity.com
 
Media
Cheston Turbyfill
Office: (210) 515-7757
cheston.turbyfill@acelity.com





ACELITY L.P. INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations
(dollars in thousands)
(unaudited)

 
Three months ended June 30,
 
Six months ended June 30,
 
2015
 
2014
 
% Change
 
2015
 
2014
 
% Change
Revenue:
 
 
 
 
 
 
 
 
 
 
 
Rental
$
180,397

 
$
173,629

 
3.9
 %
 
$
353,236

 
$
338,606

 
4.3
 %
Sales
281,248

 
285,549

 
(1.5
)
 
552,459

 
563,207

 
(1.9
)
Total revenue
461,645

 
459,178

 
0.5

 
905,695

 
901,813

 
0.4

 
 
 
 
 
 
 
 
 
 
 
 
Rental expenses
77,869

 
85,889

 
(9.3
)
 
156,047

 
170,538

 
(8.5
)
Cost of sales
75,509

 
80,082

 
(5.7
)
 
148,923

 
161,472

 
(7.8
)
Gross profit
308,267

 
293,207

 
5.1

 
600,725

 
569,803

 
5.4

 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative expenses
158,994

 
169,765

 
(6.3
)
 
306,757

 
345,377

 
(11.2
)
Research and development expenses
14,391

 
18,233

 
(21.1
)
 
29,069

 
35,723

 
(18.6
)
Acquired intangible asset amortization
44,712

 
48,754

 
(8.3
)
 
90,589

 
99,443

 
(8.9
)
Wake Forest settlement
—

 
198,578

 
—

 
—

 
198,578

 
—

Operating earnings (loss)
90,170

 
(142,123
)
 
—

 
174,310

 
(109,318
)
 
—

 
 
 
 
 


 
 
 
 
 
 
Interest income and other
67

 
127

 
(47.2
)
 
214

 
222

 
(3.6
)
Interest expense
(107,374
)
 
(101,805
)
 
5.5

 
(212,100
)
 
(204,000
)
 
4.0

Foreign currency gain (loss)
(6,799
)
 
3,852

 
—

 
12,601

 
4,088

 
—

Derivative instruments loss
(919
)
 
(4,297
)
 
(78.6
)
 
(4,267
)
 
(4,300
)
 
(0.8
)
Loss from continuing operations before income tax expense (benefit)
(24,855
)
 
(244,246
)
 
(89.8
)
 
(29,242
)
 
(313,308
)
 
(90.7
)
Income tax benefit
(7,224
)
 
(90,423
)
 
(92.0
)
 
(7,080
)
 
(112,425
)
 
(93.7
)
Loss from continuing operations
(17,631
)
 
(153,823
)
 
(88.5
)
 
(22,162
)
 
(200,883
)
 
(89.0
)
Earnings from discontinued operations, net of tax
—

 
1,106

 
—

 
—

 
1,783

 
—

Net loss
$
(17,631
)
 
$
(152,717
)
 
(88.5
)%
 
$
(22,162
)
 
$
(199,100
)
 
(88.9
)%









ACELITY L.P. INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
(in thousands)

 
June 30,
2015
 
December 31,
2014
Assets:
(unaudited)
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
141,152

 
$
183,541

Accounts receivable, net
371,295

 
370,483

Inventories, net
184,118

 
178,222

Deferred income taxes
51,166

 
63,025

Prepaid expenses and other
32,145

 
27,563

Total current assets
779,876

 
822,834

 
 
 
 
Net property, plant and equipment
278,126

 
288,048

Debt issuance costs, net
66,044

 
77,896

Deferred income taxes
30,584

 
31,692

Goodwill
3,378,298

 
3,378,298

Identifiable intangible assets, net
2,312,809

 
2,397,251

Other non-current assets
4,686

 
4,694

 
 
 
 
 
$
6,850,423

 
$
7,000,713

 
 
 
 
Liabilities and Equity:
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
48,073

 
$
51,827

Accrued expenses and other
340,314

 
343,484

Current installments of long-term debt
25,382

 
25,721

Income taxes payable
4,661

 
1,305

Deferred income taxes
45,013

 
113,658

Total current liabilities
463,443

 
535,995

 
 
 
 
Long-term debt, net of current installments and discount
4,812,089

 
4,815,290

Non-current tax liabilities
34,336

 
33,300

Deferred income taxes
819,537

 
792,157

Other non-current liabilities
84,697

 
163,258

Total liabilities
6,214,102

 
6,340,000

Equity:
 
 
 
General partner’s capital
—

 
—

Limited partners’ capital
648,531

 
670,787

Accumulated other comprehensive loss, net
(12,210
)
 
(10,074
)
Total equity
636,321

 
660,713

 
 
 
 
 
$
6,850,423

 
$
7,000,713










ACELITY L.P. INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

 
Six months ended June 30,
 
2015
 
2014
Cash flows from operating activities:
 
 
 
Net loss
$
(22,162
)
 
$
(199,100
)
Adjustments to reconcile net loss to net cash provided by operating activities:
 
 
 
Amortization of debt issuance costs and discount
20,311

 
19,409

Depreciation and other amortization
132,334

 
160,528

Amortization of fair value step-up in inventory
—

 
6,680

Provision for bad debt
3,266

 
8,239

Equity-based compensation expense
1,305

 
2,103

Deferred income tax benefit
(30,224
)
 
(141,532
)
Unrealized gain on derivative instruments
(3,078
)
 
(3,785
)
Unrealized gain on foreign currency
(16,683
)
 
(3,104
)
Change in assets and liabilities:
 
 
 
Decrease (increase) in accounts receivable, net
(968
)
 
27,186

Increase in inventories, net
(10,856
)
 
(10,881
)
Decrease (increase) in prepaid expenses and other
(4,685
)
 
9,765

Increase (decrease) in accounts payable
(3,533
)
 
4,412

Increase (decrease) in accrued expenses and other
(76,509
)
 
180,751

Increase in tax liabilities, net
6,213

 
707

Net cash provided (used) by operating activities
(5,269
)
 
61,378

 
 
 
 
Cash flows from investing activities:
 
 
 
Additions to property, plant and equipment
(29,574
)
 
(28,382
)
Increase in inventory to be converted into equipment for short-term rental
(4,144
)
 
(4,121
)
Dispositions of property, plant and equipment
1,265

 
532

Businesses acquired in purchase transactions, net of cash acquired
(2,948
)
 
(4,613
)
Increase in identifiable intangible assets and other non-current assets
(3,646
)
 
(4,230
)
Net cash used by investing activities
(39,047
)
 
(40,814
)
 
 
 
 
Cash flows from financing activities:
 
 
 
Distribution to limited partners
(55
)
 
—

Settlement of profits interest units
(1,348
)
 
(1,416
)
Proceeds from revolving credit facility
30,000

 
—

Repayments of long-term debt and capital lease obligations
(15,389
)
 
(13,271
)
Debt issuance costs
(6,256
)
 
—

Net cash provided (used) by financing activities
6,952

 
(14,687
)
Effect of exchange rate changes on cash and cash equivalents
(5,025
)
 
841

Net increase (decrease) in cash and cash equivalents
(42,389
)
 
6,718

Cash and cash equivalents, beginning of period
183,541

 
206,949

Cash and cash equivalents, end of period
$
141,152

 
$
213,667





ACELITY L.P. INC. AND SUBSIDIARIES
Reconciliation from GAAP to Non-GAAP
Supplemental Revenue Data
(dollars in thousands)
(unaudited)
 
Three months ended June 30,
 
GAAP % Change
 
Constant Currency % Change (1)
 
2015
 
2014 GAAP
 
 
 
GAAP
 
FX Impact
 
Constant
Currency
 
 
 
Advanced Wound Therapeutics revenue:
 
 
 
 
 
 
 
 
 
 
 
Rental
$
180,397

 
$
4,030

 
$
184,427

 
$
173,629

 
3.9
 %
 
6.2
 %
Sales
173,817

 
14,904

 
188,721

 
173,844

 
—

 
8.6

  Total
354,214

 
18,934

 
373,148

 
347,473

 
1.9

 
7.4

 
 
 
 
 
 
 
 
 
 
 
 
Regenerative Medicine revenue:
 
 
 
 
 
 
 
 
 
 
 
Sales
103,529

 
1,496

 
105,025

 
107,524

 
(3.7
)
 
(2.3
)
 
 
 
 
 
 
 
 
 
 
 
 
Other revenue:
 
 
 
 
 
 
 
 
 
 
 
Sales
3,902

 
383

 
4,285

 
4,181

 
(6.7
)
 
2.5

 
 
 
 
 
 
 
 
 
 
 
 
Total revenue:
 
 
 
 
 
 
 
 
 
 
 
Rental
180,397

 
4,030

 
184,427

 
173,629

 
3.9

 
6.2

Sales
281,248

 
16,783

 
298,031

 
285,549

 
(1.5
)
 
4.4

  Total
$
461,645

 
$
20,813

 
$
482,458

 
$
459,178

 
0.5
 %
 
5.1
 %


 
Six months ended June 30,
 
GAAP % Change
 
Constant Currency % Change (1)
 
2015
 
2014 GAAP
 
 
 
GAAP
 
FX Impact
 
Constant
Currency
 
 
 
Advanced Wound Therapeutics revenue:
 
 
 
 
 
 
 
 
 
 
 
Rental
$
353,236

 
$
7,638

 
$
360,874

 
$
338,606

 
4.3
 %
 
6.6
 %
Sales
338,237

 
26,987

 
365,224

 
339,662

 
(0.4
)
 
7.5

  Total
691,473

 
34,625

 
726,098

 
678,268

 
1.9

 
7.1

 
 
 
 
 
 
 
 
 
 
 
 
Regenerative Medicine revenue:
 
 
 
 
 
 
 
 
 
 
 
Sales
207,698

 
2,910

 
210,608

 
214,180

 
(3.0
)
 
(1.7
)
 
 
 
 
 
 
 
 
 
 
 
 
Other revenue:
 
 
 
 
 
 
 
 
 
 
 
Sales
6,524

 
633

 
7,157

 
9,365

 
(30.3
)
 
(23.6
)
 
 
 
 
 
 
 
 
 
 
 
 
Total revenue:
 
 
 
 
 
 
 
 
 
 
 
Rental
353,236

 
7,638

 
360,874

 
338,606

 
4.3

 
6.6

Sales
552,459

 
30,530

 
582,989

 
563,207

 
(1.9
)
 
3.5

  Total
$
905,695

 
$
38,168

 
$
943,863

 
$
901,813

 
0.4
 %
 
4.7
 %

(1) Represents percentage change between 2015 non-GAAP Constant Currency revenue and 2014 GAAP revenue.





ACELITY L.P. INC. AND SUBSIDIARIES
Reconciliation from GAAP to Non-GAAP
Selected Financial Information
(dollars in thousands)
(unaudited)

 
Three months ended June 30,
 
Six months ended June 30,
 
2015
 
2014
 
2015
 
2014
 
 
 
 
 
 
 
 
Net loss
$
(17,631
)
 
$
(152,717
)
 
$
(22,162
)
 
$
(199,100
)
Earnings from discontinued operations, net of tax
—

 
(1,106
)
 
—

 
(1,783
)
Interest expense, net of interest income
107,288

 
101,706

 
211,939

 
203,811

Income tax benefit
(7,224
)
 
(90,423
)
 
(7,080
)
 
(112,425
)
Foreign currency (gain) loss
6,799

 
(3,852
)
 
(12,601
)
 
(4,088
)
Depreciation and other amortization
66,003

 
78,499

 
132,334

 
160,528

Derivative instruments loss
919

 
4,297

 
4,267

 
4,300

Management fees and expenses
1,365

 
1,199

 
2,677

 
2,189

Equity-based compensation expense
770

 
1,162

 
1,305

 
2,103

Acquisition, disposition and financing expenses (1)
1,351

 
1,728

 
3,931

 
4,538

Business optimization expenses (2)
7,222

 
20,073

 
13,350

 
38,382

Wake Forest settlement
—

 
198,578

 
—

 
198,578

Other permitted expenses (3)
6,028

 
8,805

 
10,766

 
24,950

Adjusted EBITDA from continuing operations
172,890

 
167,949

 
338,726

 
321,983

Adjusted EBITDA from discontinued operations (4)
—

 
1,799

 
—

 
2,899

Total Adjusted EBITDA
$
172,890

 
$
169,748

 
$
338,726

 
$
324,882

 
 
 
 
 
 
 
 
Adjusted EBITDA from continuing operations as a percentage of revenue
37.5
%
 
36.6
%
 
37.4
%
 
35.7
%

(1) Represents labor, travel, training, consulting and other costs associated with acquisition, disposition and financing activities, such as the acquisition of Systagenix, technology acquisitions and the amendment of our senior secured credit facility.
(2) Represents labor, travel, training, consulting and other costs associated exclusively with our business optimization initiatives.
(3) Represents charges for the amortization of the fair value step-up in inventory and other permitted expenses.
(4) Adjusted EBITDA from discontinued operations includes the (gain) loss from discontinued operations, adjusted as defined in our senior secured credit agreement.


 
 
 
As Reported % Change
 
Constant Currency % Change (1)
 
2015
 
2014
As Reported
 
 
 
As Reported
 
FX Impact
 
Constant
Currency
 
 
 
Three months ended June 30,
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA from continuing operations
$
172,890

 
$
4,491

 
$
177,381

 
167,949

 
2.9
%
 
5.6
%
 
 
 
 
 
 
 
 
 
 
 
 
Six months ended June 30,
 
 
 
 
 
 
 
 
 
 
 
Adjusted EBITDA from continuing operations
338,726

 
8,884

 
$
347,610

 
321,983

 
5.2
%
 
8.0
%

(1) Represents percentage change between 2015 Constant Currency EBITDA and 2014 As Reported EBITDA.




 GRAPHIC 3 acelitycompaniesaa01a01.jpg begin 644 acelitycompaniesaa01a01.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_[0`L4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!`!+`````$``0$L`````0`!_^$`2D5X:68``$E)*@`(`````P`:`04` M`0```#(````;`04``0```#H````H`0,``0````(`D0`````````L`0```0`` M`"P!```!`/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H< M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T- M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,O_``!$(`-P#L0,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0`` M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$% M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U M-CH.$A8:'B(F* MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G: MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(# M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q M$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8 MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z***`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****` M"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***"<#-`!14!OK120 MUU`".QD%/CGAF'[J5'_W6!H`DHHHH`****`"BBB@`HHHH`****`"BBB@`HHH MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBJ]]>P: M=937=RVV&)=S'^GUH`G9E12S,%4#)).`*YG4_'>C6!*12-=RCM",J/\`@1X_ M+-<%KGB74O$=UY"!UMRV([:+)SZ9Q]XU"-!6VYU:_@LO^F0_>R_]\KT_$B@# MD4$:_P`EIA\6Z\Q).IS\^F!_2@"SX8AOU\2Z M>98[D()1DLK8KIOB5;.MK97T;,I5S$Y4XSD9'\C^=8?ASQ'K%WXBL8)]0FDB M>7#*QX(KK?B"!_PBS\=)DH`\I^T3?\]I/^^C7L_A2V-KX8L%;)9XQ*Q)Y.[G M^1%>*5[]:(L=G`BC"K&H'TQ0`75U#96LMS<.$BB4LS'L*\3U?6+C5=5GO6=T M$C?*@;[JC@#\JW_''B<:GU8_ASP]/X@O_*3*6Z8 M,TN/NCT'N:`)O#>AW_B"\VK++':H?WLV3Q[#U->N6-C;Z99);6Z[8D'4G)/J M2?6BQL;;3;..UM8Q'#&,`#O[GU-<1X_\1O&QT:T?:2H-PZGG!Z)^7)_#WH`D M\0_$%('>UT<+(XX:X894'_9'?Z]/K7"7NK:AJ3EKR\FFR?NLW`^@Z"DTS3;G M5KZ.SM$W2/Z]%'E4=:U1[<"PL'B;59U)@B<]N['MP,GGKBN/N+V]UUH-'U!+ MG[2&Q&`NP3'^_*H`P@([>]`&_8^(=5U.VFCM--07D1(9Y"P@!_NYZEO8<>]< MV+JXDN?L[+/!=3*`8)'D9)`6Z@9=D[<\>Q%;VG:/K=Q%<:=JT[_8`<>8LF)) M#_LX^ZF!T/\`^KIK*RM]/M$M;6(10I]U10!P,&F^*;V*Z^FNBN`'4,`0 M1D9Y'(-`%+2=8L]:M!<63ZE?R>&/'EY+:9\OS`TD8.`ZL M`Q'Z\>E>IV]Q'=6T5Q"VZ.50ZGU!&10!+117DFK>+];BUB]C@OW2%)W5%"+P MH8@=J`/6Z*KV!D;3K8S,6E,2EV/=L#)JQ0`5#%>6L\C1PW,,CK]Y4<$CZ@50 M\20WEQX>O8K#=]I9,*%."1D9`^HS7G?A#1-6_P"$CMI_LT]O%"VZ221"HQCD M<]<]*`/6:9)+'"NZ6147U8X%4-?U4:-HMQ>[0SH`$4]"Q.!_C7F.BV%WXRUQ MQ?7DA"(9)')R0,@84=!U^E`'K<=U;S-MBGB<^BN#4M(8]8@L)9Q,7G$+),@)!S@\CG]:]5H`****`"HIKB"W7=/-'$/5V"_P`Z MEKQ'Q-(9?$^I,3G%PR_D>^`HO,\66[?\\T=O_'2/ZT`>O45S5YHEX/- MDL%BAF%W]HC88`("``'VR6X]\UL:3:/8Z;%:R')BW*#G.5W'!_+%`%VBBB@` MHHHH`****`,W5=>TW10GVZY$;/\`=0`LQ'K@=JM65[;:A:I<>G-:_P]@,/A<2%L^=,[@>G1(FMVEDCMXT4PJI(!R.6^N3+*KMU90<` MG^7X5=UO1;76]/DMIXUWX/ER8Y1NQ!K+\#ZE#=Z!%:;@+FTS')'GG&3@_3^N M:`.FHJCJVJVVCV$EWN'TGXA7USK$$%U;P?9YI!'B,$,F3@ M'.>:`/1J***`.)\7>-)-,N&T[3MOVE1^\E89"9[`=S7'Q#Q1K:F>-M0N$)^\ M&8+^';\JHWC+)X@G:[+;&NF,OKC=S7N$'D_9X_L^SR=H\O9]W;CC'M0!X^\G MBK11YCOJ4"#NQ8I_45Z)X.U:[UC0OM-XRO,LK)N"@9``[#ZUT!&1@UR.L^*K M?PO?FQ320$91*&C8(&SU.`.N10!UU%9^BZM%K6E17T2%`^04)R5(.,5H4`%% M<2WQ$A;4#:6^FR3$R^7&PE`W\X!Z=ZVM;\6:9H3^5.[2W&,^3$,D?7L*`-RB MN"/Q.@R<:7(1ZF4?X4G_``LZ'_H%R?\`?X?X4`:GB'QM!H=Z]DMI)/.J@DE@ MJC(R.>3^E;VE7C:AI5K>,@1IHEL2WRPF(.%&PMG&!CK73 MZ7\0HM/TNULSISN8(U0L)0,X'7I0!Z317`_\+.A_Z!:.2TEK^-M)TF5H-S MW,Z\,D(!"GT)/'\ZQO\`A9T.>-+D_P"_P_PH`[VBN!_X6=#_`-`N3_O\/\*G MM/B&U]=);6NC32S.<*JS#_"@#MZ*YW5_&FE:1(T+,\]PO#10@':?0GI6/'\3 M;0R8DTZ=4]5<,?RX_G0!W5%9^DZW8:U`9;*8/M^^A&&7ZBK-Y>VUA;-<7?$C389"MK;3W`'\1P@/TSS^E10?$RR>0">PGC7^\C!\?A MQ0!W-%5-.U.SU:V%Q93K+'T.."I]".HKF=6\?PZ7JEQ9?8))3"VTOY@7)QZ8 MH`[&BN9UWQ<=$6UD;3I)8;B(.L@D``/=>G7&/SK1T'7;;7[#[3`"C*=LD;'E M#_A[T`:M%5K^^@TVPFO+AML42[C[^@'N3Q7,:1XZ_MG4XK*#2Y,N?F;S00B] MV/%`'84444`%%%%`!1110`4444`%/"LG_75/YUU-\G,MQ,\LK=7D;)_,T`:OV3P_; M?\?&I75VW=;2':/^^G_PI?[1T&'B'0GF(Z/<7;?R4`5>TCP1-JJJ_P#:=BJG MJL4GFN/J!Q^M=';_``TT]0/M%]3IIJ_C*Y_F:`.* M\.^(KFZ\064#VM@JO)@M';*K#Z$=*ZOX@_\`(JO_`-=D_G6E:^%]%L[F.XM[ M!(YHSE6#-P?SK-^(/_(JO_UV3^=`'DE>D>-?%`LX6T;3Y/WI7;/(#]P?W1[G MOZ?R\WISLS2,TA)ZN9;R[EN9FW22N78^YKV#QG*8O".H,O4JJ_FP']:\9H`] M7\`:0EEH@OG7]_=_-GT0'@?U_$5UM4=%18]"T]%&`+:,#_OD5>H`****`"LK MQ+_R+.I?]>[_`,JU:RO$O_(LZE_U[O\`RH`\0KV_PU_R+.F_]>Z?RKQ"O;_# M7_(LZ;_U[I_*@#5HHHH`****`"BBB@`JG>:K8Z?-!%=W,<+SDB/><`XZ\]NO M>KE>2>/KXW7B:2$$[+9%C`[9QN/\\?A0!W$F_P#X3,_8]/3>;4F:\D#$=/E" M\XZXSW/X5>T/3;FPMF:_NC=7LC%GE)R%!_A7/1?:O-_"GB#6;;4+?3[5OM,4 MC!1!*7>);P7_`(DO[A3E3*54^H7Y0?R%>D^`KAI_"L*L?K^GQ]FN8P?IN&:`/DVOVF^F\J'<% MW;2W)]@":JV'B32-4:5;2\$GE(9)"8V4*OKD@5A?$F3;X?MXQU>Y7\@K?_6K M+^&MJDW]JM(H9&1(R#W!W9%`$WCKQ#IM]HJVEE>)-*9U+!,XV@'G.,=<5D^! M=8TW1Y[V74+CR2ZHL?R,V>3GH#[5;\?Z7IVEPV"V5I'`\K.6*#J`!_C4_@+0 MM/U+2KFXO;2.=A/L4OVPH/\`6@#N--U6RU>V:XL)O.B5RA;:R\X!QR!ZBLW4 M/&.B:=(8Y+L2R+U6%=^/QZ?K7*^,]4BTB/\`L'2$6VC8>9<>7QG/1?Q&"?P] MZTO!?A6TCTR+4;V!)KB<;XUD&0B]N/4]<_2@"Y#\0="ED"LUQ$#_`!/%P/R) MKI;:Y@O($GMI4EB<95T.0:YCQKH5C-H$]W';Q17%N`ZNBAUK_2,M;0CS)B3][G@9]S^@-7OB+=M-XA2WR=EO"!CW;DG\L?E71_#BU6+0 M9KC'SS3D9]E``_4F@#L418T"(H55&``,`"EHHH`Y2V\%1V_B80> M5C!;/\6>Q/IVKI;J[M[&!I[J:.&)>K.V!3IIDMX))Y6VQQJ78^@`R:\ANKV\ M\9^)88=[+'))MBC[1IU)QZX!)H`[F;X@Z%$Y57GE']Y(N/UQ5S3/&&C:K,L, M-R8YF.%CF7:6^AZ?AFK5AX?TO3K58(;.$@##.Z!F?W)/6O-_'6D6^E:VC6D8 MCBN(]^Q>`K9P<>@Z&@#UNO#'_P!.\1-GGS[O_P!"?_Z]>I>&]6DO/"$=[.^Z M6*-P['N5SR?PQ7F7AF+SO$^FKZ7"M^1S_2@#TOQU+Y7A*[`ZR%%'_?0/\A7) M?#6+=KMS+V2V(_$LO^!K?^)$NSP]#&.LERH_`*Q_PK-^&,7S:E,>PC4?^/$_ MTH`]#HHHH`****`"BBB@`HHKS34OB%J4.KS):Q0"VBD*!'4DL`<9)S0!Z40" M"",@]0:\[\.>*K/2-1O-*G.VQ-T_V:4=$!8\'VZ'/U_#12X\5>)M,W0I:Z;; M2KP[%M[CVZX'OQ7/K\.M7^V+$\EN(,_-,KDX'TQG/^G7?G?8Y_L_^O\` M+;R_][''ZUX=96]^^J);6HF2\9]@"DJP/?/I[U[JBA$5!T48&:0K%&S3$(IQ M\SD`<>YH`YJV\#Z<85.IO/?W.W#22S,,?3!Z?7-2:?X'T?3M12]B$[NC;D21 MP50]B.,\>YKH8IHITWQ2)(G]Y&!%%KCP]*C>9YUK*<)+C!!]"/6NF\#W;:QH=_HEVQ9$CQ&3R0K9&/P/ M3ZT`1_#342'O--8\$"=!^C?^RUUGB?4?[+\/7=P&Q(4\N/UW-P/RZ_A7E6C7 M)H7F^0P3&*8>@SM;_/M73_$K4MTMIIJ,"%'G2`>IX7],_G0!E>`--^V^ M(1<,N8K1?,/^\>%_J?PK&C==3\0(U_*46XN!YSD_=!;GZ5Z5X!TS[#X=6X=< M2W;>8<]=O11_7\:Y[Q/X&O%O9KW2XQ-#*Q=H5.&0GK@=Q0!V">$]`"*%TV`@ M#@G)S^.:7_A%-!_Z!<'Y&O+K76]>T%Q`L]Q`%_Y8S+D#_@+=/PKN?"_C<:O< MK8WT2173#Y'3[KGTP>AH`XKQC9V]AXEGM[6)8H55"$7H,J*[W0?#6C7.@6$\ MVGPO+)`K,Q!R217$^/?^1MN?]R/_`-!%>E>&O^19TW_KW3^5`$?_``BF@_\` M0+@_(TR3PSX=A0O+I]JBCJS<#^=@]ZR[ M+PAK^NXNKES&K\B2Z*`*7BRTTVSULIIV]VKD7,\$<8DSSDCD_7`-!_#UOK=Y//>@O;V^W]WG&]C MG&?88_E7:ZMX-TF^L)([>SBM[@*3')&-N&[9]17%>!_$-MHMW<07I*07`7]Y MC.QAGK['/Z5VNJ>,](LK%Y(+N.XG*_NXXSG)[9]!0!YWX32UE\106M[;)/#- MF,JX^Z<9!_,8_&NU\3FQ\*Z.[Z7:Q6]W='R5D0?,J]2<_P">2*Y3P-IT]]XD MAN0&\JV)DD?WP<#ZD_UK8^)S'SM-7/RA9#CW^6@"EX'\,P:P\U_?*9+>)MBQ MYX=\9.?89'US7=WGAC1KVU,#Z?!&,85XD",OT(KS70[+Q3<6!?1WG%KO(/ES MJ@W<9X)'M6G_`&9X^_YZ7?\`X%I_\50!D:=+-X8\7K&9,B&?R92.CH3@_IS6 ME\1;R:77DM2Q\F&(%5[9/4_7H/PJG-X.\47,S33V;RRMRSO<(Q/U):G>/=W_ M``DQW_>\B//UQ0!T?A/P?IDVCP7]]%]IEG&X*Q(5!G@8'7\:L^(_!>EOI-Q< M64`MKB&-I!L)VM@9P0:V/"G_`"*NG?\`7$?SJ[J__(%O_P#KWD_]!-`'F'P_ MO);?Q/%;JQ\NY1E=>QPI8']/UK/\5_\`(U:C_P!=C_*K'@?_`)'&P_[:?^BV MJOXK_P"1JU'_`*['^0H`]2N])AUOPU'9S8&Z%"CX^XP7@UYKH6I7/A3Q$T=R MK*@;RKF/V]1].H_^O7K=A_R#K7_KBG\A7"?$FQM$-K?*ZK=R'RV3NZ@?>_#I M^(]*`*'CSQ$NHW2:?:2AK6$[G93P[_X#^>:ZOP5X?_L?3/M%PF+RY`9\CE%[ M+_4__6KAO!%A:7_B.(73KB)3(D3?\M&'0?AU_"O8*`"BBB@`HHHH`****`"B MBB@`KEOB#_R*K_\`79/YUU-8/C'3I]3\-SPVR[I5(D"#JV.H'OB@#R*W,=I> M8O;1I47*O$6*,#]>Q'O6B-)L+[G3=2C5S_R[WG[IQ[!ONM^8^E0P7UM/$MKJ MD3L$^6.YC_UD8]"#PP'H>1V-2GP]<3J9-,GAU",,_-^6:`(+G0M6 ML-_$,7']H%AZ/$A_IFK"_$#7@H!EA;W, M0JG_`,)'&_\`K="TAO=8"A_0TX:YI1?+^&[0CN%FC^-?"(DB;5-.C/F(/W\8_C`_B'OZ^O\_.*^A*!GS[ M'(\4BR1L4="&5@<$$=Z]?\)>)4UZQV3%5OH1B1>FX?WA_7T/X5Q_CCPP-,N3 MJ-G'BSF;YU`XC<_T/^>U/:OILFDZK<64H.8VPI M/\2]C^(H`]@\,72WGAG3Y5.<0K&?JORG^5:U>8>`_$<>G3MIMY($MYFW1NQX M1^F#['^?UKT^@`HHHH`*RO$O_(LZE_U[O_*K6HZG9Z5:FXO9UBC'`SU8^@'4 MFJOB7_D6=2_Z]W_E0!XA7M_AK_D6=-_Z]T_E7B%>W^&O^19TW_KW3^5`&K11 M10`4444`%%%%`!7B/B8D^)]2SG/VANOUKVZO)?'^G/9^(WN0O[JZ4.IQQN`` M8?H#^-`&Q\-=+!^U:I(O(/DQ9[="Q_E^M>A5SW@>-8_"-D5P2^]B1W.\_P"& M*Z&@`HHI&944LS!549))P`*`%K'\0Q:1-I=P^JQQR16Z;CC[ZYZ8/4$G\Z9> M>)[*+2WO+$F^;?Y:1PY)+>_H/>N;L[NPN;#4I;>'[;JM\^/)N2I5F&#M0G`9 M5Z^^![4`9%UX&N9[2"_T@O-;3J'6*;"R(#TSV->FZ?9II^GV]I']V&,(#ZX' M6C3TN8]/MTO&1KD(!(4&%S["K-`&/XKE\GPMJ+9QF$K_`-]1>9XHW_\\H';^0_K0!ZQ M1110!P'Q.EQ#IL(/WFD8CZ;1_4U9^&D.W1KN;'W[C;^2C_&LCXF2YU:SAS]V M`MCZL1_[+72^`(?+\*0OC_6R._ZX_I0!SGQ,ESJ=C#_=A+?F*-O\`SR@1/YG^M=[X0B\GPIIZ>L9;_OHD_P!: M`/)]?N3=^(-0F)SNG<`^P.!^@%=S!IOCJ"WBABU&T2.-`JKM3@`8`^Y7#:]: MM9:_?6[@C;,Q&>ZDY!_(BO8M#U&+5=&MKJ-@=R`./[K`M`4$3*HCF:[FD#*6*AAN')& M>10!X[XX_P"1PO\`_MG_`.BUKO/`+!O"<`!Y61P?^^L_UKF?B/ICQ:G#J2J3 M%,@C<^CC_$?R-.^'VO0V<>%K75+G5S_9$T<5U'$S[Y`"`N0#U!]:]&\;VYN_ M"MV(_F:$K(0/0$9_0YK@/!.I1:;XDB:9@D4R&%F)X&<$?J!0!UAL?'Q!!U2U MY]%0?^R5EZAX/\4ZK(DE]=VTS(-JDOC`_!:]*HS@9H`Y6+3Y/#_P^N[:,_$UU>I:PF M&\FE.$22(#'_`'SC]:W=3\'ZUKJK+J.L1>:H^6!(CY:_0Y_7%`&OH'BZQU^= M[>*.2&=5W!),?,/8BJOC^WO+CP\!:J[HDH:94ZE<'G'<`X_R*P?`^D2V'BJ\ MBO%V7%M"0%SP:2.TA4&78<%L]%_0_E7H,G@ MO0'M_)^P*H`X=78-^>:R([VQ\,>.+NV2W:<6\Z.4V3D M+G!QP>A_G6Z&!7<",=/?TIWPSLI`M]>L" M(VVQ(?4CD_T_.JNF?#>\DE5M2N(X8AU2([G/X]!^M>B6=G;V%I':VT8CAC&% M44`>6_$#3OL7B$W"+B.Z02>VX<-_0_C6+;IB(TGB.P6WW$_:4*G MO@,.?RK;_P"$(\2W3*MQM"CH9;C_ MO0!Q/CY2/%EP2."B$?\`?(KT3PO%K!UE7:D*HQS]TC@@UG^*_"']OR)= M6TR172+L.\':X[9QTZURB?#G6BX#2V:C^]YC?_$T`8&G/'::];/?+F.*X4S! MAGHW.:]QCECEB66-U>-AD,IR"/7-<'K'P_N;M$N8+N)KTJ//#*561O[PZX)[ M^IYXK&A\!^(7/E,(HHR>2TWR_D,T`-\?WMM?>(8VM9DF6*W6-F0Y`;`2.V,#<688'MP*]2 M\-^7/X5T]64.C6ZHRL,@\8(-`'E6J7UIK'B-[EE%K:22`$QIR%[M@=6/6NIT M[P]X+NW4Q:K+*3_RSFF"$_AM!K7U+X?:3>,SVK26S@2&$ZTB"] MC4L;5SOQ_<;&3^8'YUQFB>(=1\.7XC9I/(5]LUM)GCGG`/0U[%^[N;?D+)%( MO((R&4B@#SCP!XAMK#SM-O)5B25_,B=SA=V,$$]N@KTH$,`000>017`:Q\./ M,F:72;A(U//DS9P/HPS^OYUB?\(+XB7]V(DV'TG&*`/1[SQ#IME>06;W"O7]W&#!(LBQP@G)!R,D MXQR*=XM\):IK&N-=VBQ-$8U7YGPW0A6&(/G;)DG*E M>/SJ'7_!6L7^NW=W;K"T4K[E)DP>E`'=1W4-CH<5U<.$BBMU9F/IM%>2WUW> M>+?$8V*=\SB.%#T1/_K_/J?Z4`<-K>DW7A36X_*E;`Q)!-C&TAX``+A/G@<]F]/H>G_ZJ\S\ M,ZW+XG4`%%%%`! M1110`4444`%%%%`'*>(O`]IK$CW5JPM;MN6.,HY]QV/N*\]U'P[K&C2;I[60 M*IR)HOF7ZY'3\<5[;10!XE!XFU>&,1M=F>+_`)YW*B4?^/`U+_;]K+Q=Z#IT MGJ8E:$G_`+Y/]*]6O-`TF_)-SI]N['JP3:Q_$+_`*Y7A/\`,4HF\*LI#6FJJ>Q65#_,5UDGPSL3GRK^X7TW M*K?X5`WPP0XV:LP^MOG_`-FH`R_#I\.?\)!9?9$U43^9\AE>,KGWP,UT'Q)N MA'HMM;`_--/NZ]0H.?U(IND_#[^R]5MKW^T_-\E]VS[/MS^.XU?\2^$I/$5Y M%,VH^1'$FU8_)WVLMM<('AE4JRGN M*\3UW2)=$U::RDR0OS1O_?0]#_GN#7N5<[XI\++XB6W9)U@FA)&\INRI[=?7 M^M`'F?A[79]`U);B/+0M\LT6>'7_`!':O0_$.AVWB[28=0T^1#"XB:*5#AD88(KI]#\=W^EQ+;W*?;+=1A=S8=1Z`]Q]:]&U;0=.UJ M,+>VX=@,+(O#K]#_`$KCKOX9-N)LM1&WLLR?RX'\ZKGX:ZL&^6ZLBOJ6<'_`-!JY:_#*4D&[U)% M'=8HR<_B2/Y4`<7>7][JUV);NX>:5C@%CP/8#H!]*]=\7W(MO"M^QZO'Y8'J M6(']:9I?@[1M+99$MO.F7D23G<1]!T'Y5)XGT.77]/CM([I8%60.Q*;MV`0! MU]Z`/%J]I\(3B?PII[`YVQ[/^^21_2N4_P"%8S?]!2/_`+\G_&NM\-:+-H.F MM9RW2W"^870A-NT'J.OKS^-`&S1110`4444`%%%%`!67KVB6^O::UK-\KCYH MI`.4;U^GM6I10!Q'A^[OO#MO)HU[:EYHG,D*J?\`7Q_Q",]"P/.._-;EKXNT M.Z(5+T+)_P`\Y$96SZ8QR?85K7%M!=Q>7/$LB9R`1T/8CT/O6)J7@[2=3W-. ML@F/_+9&`;\>/F^IR?>@!UUXKLXT86D,]S,O6+88B.,Y._''T!K)35H=.1N/W\8_A]NE3Q>"3&RJ^J221IG82A61/3#JP)^AR/3%: MNF>'X;&0SW)BN[K(VW#P`.,#'WN23[DYH`X_3;*PO]=$=E=76G-(QS"X_>M& M.=J[>$7'8]?>NVM]!TVUU(W\-LB3[`BX^Z@_V1T'X>_J:NQVMO%-)-'!$DLG MWW5`&;ZGO4M`!1110!SWC#1[S7-)BM+,QAA,'8R-@8`(]/4URNG^#?%&E3-- M8W5K#(R[2P?.1UQROM7I=%`'"G2_'9'_`"%8/^^A_P#$U&N@^-'E3S=7&S(W M;9V''?H!7?44`<+XL\):IKFM?:K9K<1")4&]R#QD^GO73>'=.ETG0;6QF*&2 M('=L.1DL3_6M2B@#SWQ)X,U;5]?N;Z!K812;=H:0@X"@>GM7;:5:-8:19VCD M%X841B#D$@)_",&O[;B*007B#:'(RKCT;_&N1MO#'B_1IV.G@ MC/4Q3KM;ZAB/Y5ZG10!P":3XYU'Y;O4?LJ'[V)%!Q_VS']:Z;P]X>BT"&8"X MDN)YR&EE?C)&<8'XGN:V:*`*][96^HVDEK=1"2&0893_`)ZUYYJ?PWNXY&?3 M;B.:+LDIVN/;/0_I7I=%`'F5KI?CRQC\JW,PC'`!N(V`'MN/%:$?A_QAJ6%U M#6#;1=&"/DD?1<`_G7>T4`9>C:%;:+I[V<323+(Q>1I3G>2`#Q^%<;K7PZG\ M]YM(D1HF.?(D."OL#W'UQ7HU%`'FMI8>/K.(00-(L8&!OEB?`]LDD5?B\(:[ MJK9US67\H\F&)RV?Y*/R-=W10!SWB70[C4?#L6F:>4&QD'[UL?*H/?'7I6?X M-\+WV@W=S->&`B2,*OEL2>N?2NQHH`X7Q;X2U37-:%U;-;B(1*@WN0>,D]O> MNF\.Z=+I.@VMC,5,D0;=L.1DL3_6M2B@`HHHH`****`"BBB@`J.>"*Z@>">- M9(I!M9&&014E%`&7IGAW2M'F>:RM%CD88+EBQ`]!DG%:E%%`'G?B[6WT?QG: MW5IM:6*W"S*>C`DG:?PP?RKL]$UFWUW35O+=649*NC=58=1^H_.L;Q)X+BUZ M]6\CNC;3;0KY3<&`Z'J,&MC0]&@T+3$LH&9^2SNW5F/?^7Y4`<#XTT'5I_$4 MMU#:SW,,P78T2%MN`!@@=.?YUW/A>RNM.\.VEK>']\BG*YSM!)('X`UKT4`% M%%%`!1110`4444`>5?$/4OM>O+:*V8[1-I_WFY/Z8'X5W/A'3?[+\-VL3+B6 M4>=)]6_P&!^%8\GP]AN-4:]N-0>3?,970Q`;LG)&XZ_G7)^&_&5QH*?8;R!I;56.%Z M/&>X&>O/8UZQ65J?AS2M7):[M$:0_P#+5?E;\QU_&@""S\8:%>J"NH1Q-W6? M]V1^?'Y&IY_$VB6T1D?5+5@.TVA%M:PP*&M-T,$VD),Q&&FD.YR/Z?A6O0`4444`%%%%`!1110`4444`%% M%%`!7(>(O`T>LZD;VWN5MGX,?7J*Z^B@#*\/:7!Z;A_7<3_WS27G_`!(_B1;W(^6WU)-C>FX\?S"G\:`.XIHD0OL# MJ6';/-NTG'Y<,3ZTX?#C1Q&!Y]YYF/OAUZ^O MW:`.PIJNK@E6#8]#FN(\22S:KXBM/#<%R;:T6,-.P.,C&<'\`,>YJAKFB1>% M(H-5T6^E#QR!9$>0'<#],9'J/>@#;\47]W:^)-`@@N)(XIIPLB*V`XWJ,'UZ MFM2:PU5_%-O>QW@73$C*R6^]LLV&YQC'4COVKG?$TXN?$'A2X48$LJ.!]70U M/>NX^*FG)N.TVYXSQ]R2@#6FURXC\9V^C+'%]GD@,C,0=^[YNASC'`[5O5Y? M)X9M1XY32#9#(/,SM)ZXQ^E:_B?P^NE>#RME/3D@D]A MZ?B6_*@#9\0:PVD6"-!$)KN>00V\1Z,Y]?:J,?AW4KI!+J7B"_$S#)2S<1(I M]!QS3=:'F^,_#L3\H//?'N%R/Y5TU`&;I>F7&G/+YNIW-XC`!5GP2OKSWK2J M&[N%M+.>Y?[D,;2-]`,URNDZ!%X@L4U776ENI;G+I%YC*D2YX"@$=J`.PHKD MXX'\,>(;*UMY96TR_P!T?E2.6$4@Z;2>Q_SVJMIFE+K&KZVEW=7!M([UO]'1 MRJL3W8CD]!Q0!VM%<1J&CKHFLZ=;Z/=3V,&H%H9E1BX&,'(W9P>O/:K>I^$= M-@TRYN[=KE+Z&-I5NC.Q?TJ_7GM[=74GP\O([B=I);6[^SB7/+!7&":WM>EN+_6;+0;>=X$ MF1I[F2,X;RQP`#VRFR:GHIDM;NU'F$^:S"4#J&!//&:B MUB\BU/5M(@O[E[72;JU$_#[%D<_PLWIC'Y^]`':T5AV/A71;*YBN[&!HW4[@ MR3N0WUR2#6Y0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`! M1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%% M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%5[ZZ2QL+B[?[L,;.1ZX&:L57OK*#4;*2TN5+0R`!@&()YSU'TH`\[\->' M]7U*REU2VU=[(W,C;MH.7P>I(([DT>)O#FKV6FC4+K6)+W[,X(#`Y3)`R"2> M^*]$LK*#3K.*TMDV0Q#"KG..]+>6D-_:2VMPF^&5=K+G&10!P>KZ@J^(?#GB M&3BVE@578#A#SN_+?^E=TVHV*0>>UY;K"1G>9!MQ]:JC0--_LA=*:W#V:DE4 M=B2I))R#U!Y-9*?#_04EWF*=US]QI3C].?UH`Y_Q#:6,OCN"34VQI]Y$I656 MP/NX!S]0/SK5G\(^$K6$2SW/EQGHS7(`/T]:Z.]T/3=0T^.RN+96@B`6,`D% M`!C@]:R8/`.@PR[VAFE&B6%[Y=8?BI;M*P16M_E+'`/RL/Z5UES%;ZKIUQ;K(DDFZZ4:\C;S$&%DC;:P'I[U8TC1[/1+0VUDKK&S;SN8L2 M<`9_04`>:KK$UOX1N/#I!^VBZ\@(.NPG)`_X$"/QKTW2K%=-TJULUQ^YC"DC MN>Y_$YKC;6QMM7^)-U<01`6]D0TK#H\HX_#G_P!!KOJ`.8\6![*YTK6U1F2R MF(FVCD1OP3_GUKHX+B*Z@2>"19(G&5=3D$4YT21&1U5D8896&01Z&L%O!FD> M8S0I<6X8Y*0SLJY^E`&EJJ"[TV]L8W0W$MM(JID9Y4C./3)%4?"-Y%=>&K-4 M/SP((9$/567CG^=6-,\/:9I$C2VEOMF88:5V+,1]2:BN_"^F75XUV$EMYW^^ M]O*T>[ZXH`HZ[(MYXIT2PA(:6&4W$H'.Q0.,^F:=X7_Y"OB'_K^-:FEZ'8:. M'^R0XDD^_([%G;ZDU-::=;6,US+`A5[F3S)26)RW]*`,7Q'_`,C#X<_Z^'_D M*V=7_P"0+?\`_7O)_P"@FENM.MKRYM;B9"TEJQ>(AB,$_P`ZGFA2X@DAD&4D M4HPSC((P:`.%C_Y!7@W_`*^%KNKB>*UMY)YG"11J69CT`%V<5U#>%/#EO;,9+"!8D7+.['@>I)-:EWIMG?6)LKBW1[?``3 M&`N.F,=,>U9C5F)H M&G)8PV2PL((9A.B[SPX).?S-:=`'G-]_R(VM?]A-_P#T-:U=?LK.7QKIS:DA M-K<6Q@0[R@$@8D9((]_P`U:;Z983Z?%926TD3RPB:Y6)[,R%DD!ZX!YS_C7:5CV?AG3;.\ M6[V2SW"_X>)YH4D:)M\989*GU%3444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` M4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1 M110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%% M%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444 M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110` :4444`%%%%`!1110`4444`%%%%`!1110!_]D_ ` end GRAPHIC 4 acelitylogoaa01a01.jpg begin 644 acelitylogoaa01a01.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_[0`L4&AO=&]S:&]P(#,N,``X0DE-`^T` M`````!`!+`````$``0$L`````0`!_^$`2D5X:68``$E)*@`(`````P`:`04` M`0```#(````;`04``0```#H````H`0,``0````(`D0`````````L`0```0`` M`"P!```!`/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H< M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T- M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R M,C(R,C(R,C(R,O_``!$(`BL">P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0`` M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$% M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U M-CH.$A8:'B(F* MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G: MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(# M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q M$R(R@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8 MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?Z***`"BBB@`HHHH`****`"BBB M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`**ADN MH8N&D&?0DD/XJ:N1:C;2\>9M/H_%`%NBD!!&0?4\"L^:_FFX9SCT'`JB7IN^F(G\PYIID M-0%Z-U`$V^C?FH=U`:@";=1NJ+-*#0!+FC-,#4N:`%S2TE%`"TM(*<*`)(II M83F.1E^AXK0@U=A@3)G_`&E_PK,`I0*`.DAN(IUS&X;V[BI*YI-R$,I(([@U MHV^ILN%G&1_>'6D,U**:DBR(&1@RGN*=0`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`44 M52O]1CLDQ]Z4]%_J:`)[BYBM8]\K8]!W-<_>:G+=$J#LB_NCO]:ISW,EQ(9) M6+,?TJ$M3$2EZ87J,M32:`)"]-WU&332:`)=]+OJ$&ES0!-OI0U0@T\&@"4- M3@U1`TX4`2@TX&HP:<*`)!2TT4Z@!PIPI!3@*`%`IX%`%/`H`0+2[M M7Z0!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444 M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110 M`4444`%%%%`!1110`4451U+4%L8>,&5ONK_6@!FIZFMFGEH0TQ'`_N^YKF9) M6D=G=BS,6IA:F%J:30`_=2;J8332:`)"U-W4S M-)F@"4&ES46:<#0!*#3@:B!IX-`$H-/6H@:D%`$@IXJ,5(*`'BG"FBGKUH`> M*>*:*>!0`]14@%-45*HH`4"G[:`*D"T#(]M(5J?;2%>*0%1TJY9WI!$4Q]E8 M_P`C43+4$B4P-VBJ%C=[L0R'YOX2>_M5^D`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!110>!0!#=7*6ENTTG0=!ZG MTKC[FYDN9VED.6;]/:K6K7YO+@A3^Z3A??WK-)IB$)II-(33":`%)I,TTFDS M0`N:3-)FDS3`7-`IN:44`.IPIM**`)!3A3!3Q2`>M2"F+4@H`>*>*8*D%`#U MJ1:C%2+0!(M2+UIBU(M`#U%3**C45,@YH&/45*HIJBI5%(!,4;:?BEQ0!`RU M"Z<5;9:B9!Z#L*`*Y M-,)IQ-1DTQ#33#3B:8:`$HHI*`$-)2FDI@%**2EH`6G"D%.%`#A3Q3!3Q2`D M6I%J-:D6@"04\4P5(*`'BI%I@J1:`)%Z5(HI@J510!(HJ9!4:BID%(9(HJ91 M4:BI5%`"@4N*6E`H`C(IC"IB*810!5=:KNM7'%0.M`"V$_ER^4WW6Z>QK4K" M<8.16O;3>?`K]^A^M`$U%%%`!1110`4444`%%%%`!1110`4444`%%%%`!111 M0`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`&1KUUY=LL"GYI#D_05S9-7-3N/M-_(^?E!VK]!5%J8AI M-,-.-,-`#3332FFTP"DI:::0"&CO10*8`*<*2EH`44X4T4\4@'"GBF"I!0`\ M4\4P4\4`2"I!48J04`2"I%J,5(M`$JU,E0K4RT`3+4ZBH4J9:0R514RBHEJ8 M4`*!3A2"G8H`:::13S330!"PJ%Q5EA4+"@"FXJ6PE\N0N!]3P*LUC>(9ML$4(_B8L?P_P#UT`<\:C-/-1FF M(::8:<:8:`&TE+24P$-)2TE`"44E+0`M+24HH`<*<*:*>*0#EZT\4Q:D%`#Q M3UI@J04`.%2"F+3Q0!(*D%1BGB@"9:F6H%J530!86IEJ!34RM2&3H:F!J!34 MH-`$H-.S48-/S0`IIII@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`* M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH MHH`****`"N8UV7?J&SLB@?U_K73UQVH/YE_.W^V0/PXH`IDTPFGM49IB&FF& MGFF&@!IHHI,TP"FFE-)0`G>EH%`H`44X4T4Z@!13Q313A2`>*<*:*<*`'BI% MJ,4\4`2"I!40J04`2"I!40J130!*M2K4*FI%-`%A34JFJZFI5-`%E34BM5=3 M4@-(99#4[-0*U/#4`29HINZC-``33#2DTTF@"-ZKN*G:H7H`KJWES(_]U@:W MJP916U"V^"-O50:`)****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`/`S7$2'>E--`#:;2F MDI@)112&@!12BD%**`%I::*<*`'"G"FBG"D`\4X4P4\4`/%.%-%.%`$@IX-1 MBGB@"134@-1`T\&@"4&I%-0J:D4T`3`U(K5`#3U-`%D&I%:JX;BI`U`RP&IX M:H`U/#4@)0U+NJ+-+F@!^ZD)IN:0F@!":B>GFF-0!!)6K8G-G'^(_6LMQFM+ M3_\`CT'U-`BU1110,****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`([ MC_CVE_W#_*N/<5V,PS"X]5-*8*<#0`\&G@U@:`)0:<#48-.! MH`E%/!J(&F75W!8VDUU1VZ*HZF@!]Y?6NFV4MY>SQP6\0W/)(<`" MO'?%'QKNI'>V\-6XAC!Q]KN%W.WNJ=!^.?H*Y+QMXTO/&.IX4M%ID+'[/!Z_ M[;>K'].@[DX$-F7'2NFG0OJSHA1NM2Q=^,?%%_*9+C7M1))SM6X9%'T52`/R MJ?3O'7BS2I1);:]?''\$TIE3_OE\BJ4M@4Y`XJ(VIQTKJ5%-"]E8]K\&?&NV MU"2.Q\21QV4[':MW'D1,?]H'[GUZ?2O74D#*&4@J1D$`CM7J/PI^(L MNEWBD_P!P_H?;IRU:'+JB90:/H(-3@U0!J>&KF,R< M-2[JB#4H-`$NZDS3,T9H`<33":4FFF@!C5HV'_'J/J:SC6E8C%L/J:0BS111 M0,****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@ M`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****``C((KDI5P2#VKK:YJ M]39^*!X8\.230L/MUQF*V'HQZM]`.?K@=Z^? M;>-I9"[DLS')8\DFNC#T^9W9M2A=W)[.VS@D5L0Q!1TJ&",*HJVM=]K'=$22 M(,O2LYXMC$'IVK6'(J"X@W+[TT[,FI#JC+>(,*H3P;:U<%201S4E5)) MHR1[U\*_%C>)/#`@NI"^H6&(IB3RZ_P/^(!!]U)[UW@-?,'@#7SX7\96MQ(^ MRTG/V>YR>`C'[Q^AP?H#7TX#7E5H#4(-.!K(S)0:7-1@T[-` MQV:0T44`%:=J,6R#_/6LRM:)=L2#T`I`/HHHH`****`"BBB@`HHHH`****`" MBBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`** M**`"BBB@`HHHH`****`"L35(\7+'^\`:VZS]4CW(C^G!H`YV05785=E7FJCB MF(KM435,U0L*`&&FFG&FFF`AI*4TE`"THI**`%I:2B@!:6DHH`>*44S-.!I` M/S2@TP&E!H`D!IP-1@US?CO7#HGA>=XGVW-Q^XAQU!;J?P&3]<4TKNPXIR=D M>4^/-8?Q+XHE,3YM;4F&#T./O-^)_3%8UM`8^&&"*M:;;9&2*TY;,.OH1T-> MA2?*K'J_5[1]TH)Q4JTQD:-MK#!IRUT$(F%/QN&*C6I5J6;+4J7%OGD=15,C ML:VMH854N+;/(ZT1E;1F-2E;5&%=1<9Q7T7\-_$7_"0^#[625]UW:_Z//SR2 MHX;\5P?KFOG^>/@@CFNI^%7B`Z)XN%C,^VUU$"$YZ"3/R'\R5_X%6.)AS1NN MASU8WC<^AP:<#40-.!KSCD)0:<#40-/!H`E!I:C!IX-`$D:[Y%7U.*UJS;-= MUP#_`'1FM*D,****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH` M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`J M&ZC\RW=>^,BIJ*`.8F6J4BUL7D/ES,N..U9DJTQ%%Q4+59D%5V%`$)III[#F MF&F`TT4&B@`%+24M`!2TE%`"T4E+0`M+FFTM`#@:=FHZ7-`$@->-?$35SJWB MD64;9@L!Y?'0R'!8_P`A^%>HZ]JR:)H=WJ#XS%&2@/\`$YX4?F17A-BKSSM/ M*Q>1V+,QZDDY)K:C&[N=>$A>7,:]E%L05H!014$*X45.M=)[4%H03VRR+@BL M^2!HCSR/6ML/:H-I4X(P:U4DSGY7%ZDJ MU(5#"HEJ9:EFBU*-S:;A[^M85U%)#*'4E74Y5@<$'UKKBH88-9U[9AU/&:2E M;1F-2C;5'O/@_7U\2>&++4(_"/6CINN7&ASMB M&\'F0Y[2*.1^*_\`H(KVL&O/J1Y96/*J1Y96)@:>#4`-/!J""8&G`U$&IP/I M0!J6"_(S^IQ5RHX(_*A1.X'/UJ2D,****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`I:A%NC#@*3%/IN*`$HI:,4`)FEI**`%HI**`%I M:;FEH`7-**;39IH[>"2>5@L<:EV8]@!DF@#S7XIZOYD]IHL3<+^_F`/?HH_F M?Q%*EFT1^P-4$EJ&'3-6%J45-[%N$9;F0UL5/%(`5Z MBM@QJW:HWM`>E4JG&:^$SUI74,*L-:LO04PQ,.U/F3(Y&MS$G66SO(;RV M8I/`XDC8=F!R*^@O#^LP:]HMMJ,&`)5^=,_<7\#7AUS#N4\5?\'>*9/"F MHM'.&?3K@CS5')0_WP/Y^H^E8U8\RNC@Q>'YES1W/=P:<#56UNX+RVCN+:5) M89!E70Y!%6`:Y3R"4&KFGQ&6X!/W4Y/]*HH&9@J@DGH!706EN+>`+_$>6/O0 M!/1112&%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%` M!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`% M4[^#>GF`*IV1LP6_[B+G@XSD_B<_ABKIQO(Z,-3YZB\B MC86X"CBM+R!CBH[=-JBK8KL/=C!-:E7:Z=*>L@[\59P#UIIA!HN/V;7PB*01 MP:D%0FW(Y4T#S4]_K2*4FMT6EJ1:J+.1]Y/RJ5;A.^1^%2S:-2/ M(_QBIEFC_P">B_G4,WC)=R<*#VI?(1NU1K-%_P`]$_[Z%2"XA'61?SJ'[,32]3UKPW*3IU MTR1LX^`_"H\-:-NN%4ZA26$. M`">M;OC?6/[9U_[-"V;6SS&N.C/_`!'],?A6?;1[5KKI0LCUL)2Y8W?4MH," MI14:U(*T/1B/%/%,%.%(UB2"G!0>HIHIXJ&:H/)4]J/LRGM3Q4@J;EJ$7T(! M9@T[[$.U6!4HI.3*5&'8IK8\U,M@M6EJ05#DRXT8=BJE@N:E%D@[5,TJ1+N= M@H]ZZWP9X9;6I%U"[B9-.4_(&X,Y'H/[OOWZ5+;%6J4,/!SF7_`?A%$9-9O( MNG-LC#_Q_P#P_/TKT6D`"@```#@`4M9MW/D,3B)8BHYR_P"&"BBBD*3%/(I,4`,Q7-^,M>.BZ0R0-B\N M`4BQU4=V_#^>*W-1O[?2[&2[NGVQH/Q8]@/>O(-3U"?6]4DO;C@MPB=D7L!6 MM.',[G3AJ#J2N]C*MHBG49K3B90,9Q]:?'",=*>8`:[#UXPE'8*JB20=@:<)V'5/UI&BJ1+8J053%R?[GZT\71_YY_K4 MM&JJQ[EP4]:I"Z<](Q^=*)YST"C\*FQHJT30%/WJHRS`?4UFC[0_5V_#BI$L MV8Y;]:EHM59/X46FOH4Z$L?85&;NXEXC4(/S-36^G[W5%0N['`4#))KTSPK\ M/TA\N]U>,%A\R6QY`]W_`,/S]*AN*,L1B/8PYJCMY+=F#X-\`RZM*FHZL'6S M!RL;9#3?X+[]_P!:]>1$BC6.-51%`5548``Z`"G````#`HK*4FSYC$8B5>5Y M!1114F`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M444`%%%%`!1110`4444`%%%%`$4]O'<)M^+-#L6=)K]#(AP40%CGTX%-)O8:BWL:I%4M2U*TTFU-Q>2B-.P[L?0#N:Y# M4_B,"#'I5H<]/-G[?11_4_A7&7=Y=ZG*1HA0@/:E\I3VH%/%2RTD((5IXA3TI13Q4EJ,>PBQ*.U2K M&H[4@K6TGP_JFM/BQM))$S@R'Y4'_`CQ^'6I;+;A!7EHC/50.U;6B>'-1UR3 M%I#B('#3/PB_CW/L*[K1/AQ9VA6;5)?M(Q_5OT^E=K'%'#&L<2*D:C M"JHP`/85C*?8\O$9O&/NT5=]S$T#PG8:"@=1Y]V1\T[CD?[H[#]:WJ**S/"J M5)U)G0SMC`DQM4:M\%H&W/HVI-&>T5TNX?]]+R/R-< M7J/PZ\4:826TQ[A`>'M2),_@/F_2OHNBMHXB:WU-X8JI'?4^4Y(9;>0QS1/' M(.JNI!'X&E%?4MQ:V]W'Y=S;Q3)_=D0,/R-8EUX&\,79)DT:V7/_`#R!C_\` M02*T6)75'5#'+[2/G@4X5[C/\+/#,I)2.ZASVCF)Q_WUFJQ^$>@$Y%UJ0]A* MG_Q%/V\3>./I=;GC0IPKV0?"30?^?O4O^_D?_P`14B?"GP\G66^?_>E7^BTO M;1-/[0HKN>-"GBON45#JM['//-*K^%)'+:5X`T+3"KO"UY*/XK@Y'_?/3\\UU"(J M($10J@8``P`*6BLVV]S@J59U'>;N%%%%(S"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*** M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH M`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@` MHHHH`****`"BBB@`HHHH`****`"BBB@`HHKS76/B#J=OJUS!9PVZP0R-&N]2 MS'!QD\T`>E45Y0OQ'UL,"8[0C/(\L\_K7ING7@U#3;:\5"@GC63:3G&1G%`% MJBBB@`HJCJ>L6&CPB2^N5B#?=')9OH!S6/;^/=!N)A&9Y8LG`:6,A?S'3\:` M.FHIJ.LB*Z,&1AD,IR"*=0`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4 M44A(4$D@`/'.@$_\?3C_MBW^%>= MZ[?G5M9N;O\`@9L1Y[*.!^E9VRG81[I#-'<0)-"X>.10RL.A!J2N/\`:EY^F M26#GY[9LI_N'_`Y_,5V%(84444`%%%%`!1110`4444`%%%%`!1110`4444`% M%%%`!1110`4444`%%%%`!1110`4444`%%%%`!7A>K)_Q.;[_`*^)/_0C7NE> M):JG_$XO?^N\G_H1IH#,V5[9X;&/#6FC_IW3^5>-[*]E\.\>'-._ZX)_*AB- M.BBBD,\.UG4)M8U2:\F8G7,9ADV#8W4?C70ZY8+I'@:YM8)I7" M;<.[?-S(#V^M`'445Q_@S6I'C&DWI83H@>`OU9",X_(@CV^E9OC/6I;V=["R M9OL]L=T[IW;.,9]`3^?TH`]"HJKIA)TFS))),"9)_P!T5:H`****`"BBB@`H MHHH`****`"L#QAJ/V#0I$1L2W'[I?H?O'\OYUOUYKXRO_MNM&%6S%;#RQ_O? MQ?X?A0@.7VTNVIMM&VJ$7_#>H?V7KD$[-B)CYVO5/#. MH?VCH<+LBT5Q=MX^&0+JQ('=HGS^A_QK>L/$FEZB0L5R$D M/_+.7Y3_`('\*0&M1110`4444`%%->1(D9Y'5$49+,<`5SU]XTTVU)2#?=./ M[@POYG^F:`.CHK@IO'MZS'R+.!!Z.2W\L57'CC5@<[+4^WEG_&G8#T6BN$M_ M'MRI'VFRB<=_+8K_`#S70:=XITS46$8E,$IZ)-QGZ'I2`VZ***`"BBB@`KQC M5%_XFU[_`-=W_P#0C7L]>/:FO_$UO/\`KN__`*$::`S]M>O^'_\`D7M/_P"N M"_RKR;;7K6@_\@"P_P"N"_RH8C1HHHI#*]Y8VM_#Y-W`DT?7#C./IZ5GP>%= M$MI1+'IZ;AR-[,X_(DBH=8\4VND78MFADFDV[FVD`+GI^-9__">VO_/C-_WT M*`.NHJGIFHPZK8I=0;@K9!5NJD=15R@`K*\2\^&[_P#ZY'^=9EWXWL[:ZD@2 MVFE$;%2X(`)'I6;JGC*WU#3+BT6TE1I4VABPP*`.'VUI>'U_XJ'3_P#KNG\Z MJ;:LZ=<"RU*WNF4LL4@VO_`#XS?]]" MIL,ZZBN1'CVUSS938_WA746EU%>VD5S"V8Y%W+F@":BHYYDM[>2>0X2-2['T M`&37*GQ[:9.+*.YMXYX6W1R*&4^H M-`$E%%%`!1110`4457O;R'3[.2ZG)$<8R<=3["@"Q17(GQ[:YXLIL?[PJ:T\ M;V=S=1PO;2Q"1@N\D$`GUH`ZBBBB@#DO`PQ!J'_7?^E:7B\9\+W@_P!S_P!# M6GZ!HTFCQW*R2K)YLNX;1T%6=:L'U/2)[.-U1Y-N&;IPP/\`2@#GK[0YK[0= M*OK#*W\%O%M*G!8;1QGU'^-0ZCHJZ/X)GC8`W,K(TS^IW#C/H*ZZQMS::?;6 MS$,T42QDCO@`56US3GU72I;2-U1V*D%NG!S0!/IG_()L_P#K@G_H(JU4-K"; M>S@A)!,<:H2.^!BIJ`"BBB@`HHHH`****`"BBB@"IJ=ZNG:;/='&8U^4'NW0 M#\Z\E-K[)@L$/3]Y)_(#^?Z5Q^VFA$:QEF"J"23@`=ZV M_$&@_P!DQV;J.'C"R'/_`"T'7^?Z5+X4T[[9K"RLN8[<>8>._P#"/SY_"NSU MW3_[2TB:`#,@&^/_`'A_CT_&@#RO;72^"[_[+JC6KG$=PO'^\.GZ9_2N?VT^ M%W@F2:,E71@RGT(I@>O457LKI+VRAN4^[(H;'H>XJQ4C"BBB@`HHI&8*I9B` MH&23VH`BNKJ"RMWGN)`D:]2:\_UKQ1=:D6AMRUO:],`_,X]S_3^=,\0:R^K7 MF$)%K&<1KZ_[1K'VTT(BVT;:LP6TMS,L4$;22-T51DUT=GX)NI5#7=PD&?X5 M&X_X?SI@!]/"_/<7)/J"H_I39/`]D1^ZNKA3_M;6_H*5P."VT;: MZNZ\$7D8)MIXIAZ'Y#_4?K6%=Z;=V+;;FWDB]"1P?H>AI@=_X5FDF\/6QD8L MR[E!/H"<5LUC>%HGB\/VX=2I)9@#Z$G%;-2,*I:IJEOI-H9[AO9$'5CZ"K,\ MT=O`\TK!8T4LQ/85YCJ^I2ZM?-/)D(.(T_NK_C0`W5M:O-7E)F?;$#\L2GY1 M_B?>LW;4NVKFGZ1>:G(5M8BP'WG/"K]35",[;1MKM[;P,@4&ZO&)[K$N,?B? M\*LGP1IV/EN+H'W93_[+2N!Y_MHVUUE_X*N8$+VDRS@<["-K?AV/Z5S+Q-&[ M(ZLKJ<%6&"#3`W_#_BB:P=;:\9I;4\!B3ZBO M_$SN_P#KL_\`Z$::`H[:]6T+_D!6/_7%?Y5Y=MKU+1/^0'9?]<5_E0Q%^BBB MD,\V\7C/B.?_`'4_]!%86VN@\6C/B&?_`'4_]!%8FVJ$=]X)&-";_KLW\A71 MUSW@P8T-O^NS?R%=#4C/'[Q?]-G_`.NC?SJ';7?7?@JWGN9)8[J2,.Q;:5W8 MS^-9^H^#X['3Y[H7C.8UW;3'C/ZTQ'([:-M2[:L6-H+R_@MBQ02N%W8SC-," MEMHVUW'_``@L7_/^_P#W['^-'_""Q?\`/^__`'['^-*X'#[:]0\,<>'+/_=/ M_H1K''@6'(S?OC_KF/\`&NGL[2.QLXK6'/EQC`R>30QDDT23P20R#*2*58>H M(P:\CO+1[*]FMG^]$Y7/K[UZ_7#^-;#R[R*]5?EE&QS_`+0Z?I_*A`^=IDEHQ^:W;*_P"ZW/\`/-<+MK8\,7GV'6XMQQ'-^Z;\>GZXH8CTFBBB MD,****`"N0\*[[[-I7D*<27!V_\![_`-!^-`'$:A=-?ZA/=-G]XV0#V'8?EBJV*?MJYI5B M=0U*&WP=K-ESZ*.35".S\+6'V+1TD88DG_>'Z=OTY_&MND`"J`!@#@`4M2,\ MX\1Z?]AUB4*,1R_O$_'J/SS63MKOO%EA]JTP3J,R6YW?\!/7^A_"N$Q30CK_ M``9?;H9K%SRA\Q/H>H_/^==77F6E7AT_4H+D9VJV''JIX->F`A@"#D'D&AC% MHHHI`%<[XNOS;:,[\I#%8(>9/GD^ M@Z#\_P"5<;MK4URX^UZST72'U:^$62L2?-(WH/3ZF MO1[>WAM8%A@C"1J,!169X9LA9Z/&Q&))_P!XQ]CT_3^=;%)C"BBB@`KG_$VA MI?VS74*?Z5$,G`^^H[?7TKH**`/(MM26\TEKH#_B977_79_YFO5*\NU`?\3*Z_P"NS_S--`4]M>G:+_R!++_KBO\`*O-< M5Z7HW_(%L_\`KBO\J&(O4444AGGGBL9\03_[J_\`H(K%VUN^*1_Q/YO]U?\` MT$5BXJA'=>#AC1&_Z[-_(5T%8'A`8T5O^NS?R%;]2,*SM?\`^0%>?]_Y`=Y_USH`\SVU>T4?\3NR_Z[+_`#JIBKVC#_B=6?\`UV7^=4(],HHHJ1A1 M110`5G:[8_VAI$\(&7`WI_O#_./QK1HH`\BVT`$$$'!'((K6UZQ^PZO,@&(W M/F)]#_\`7R/PK,VU0CT[2[S[?ID%S_$Z_-_O#@_K5RN3\&WGRSV3'I^\3^1_ MI765(PHHHH`S==O?L.CSR@X=AL3ZGC_Z_P"%>:;:ZOQE>;[B&S4\1C>WU/3] M/YUR^*:$$,#SSQPQC+R,%4>YKU6UMTM+6*WC^[&H4?A7%>$K'S]4-PP^2!/`_K7=4,84444@"BBB@`HHHH`****`"BBB@`HHHH`****`"O/_`!'>_;=7 MD"G,/2O.#RMZC!JEQ'/%"\;A=K;CG/I_6FA&3BN^\-7OVO241CF2#]V?IV M_3^5<)6SX9O?LNJK&QQ'.-A^O;_#\:&!W=%%%(85Y?>N9KZXE/\`'(S?F:]0 MKROJD:)"(-%M$`ZQAC]3S_6O.J].M`!9P`=!&O\J&(FHHHI#"BBB@ M`HHHH`*CGD\FWDE_N(6_(5)5/5CMTB\(_P">+#]*`/-2"3D]32QQF214'5B` M*7%'0Y%4(]21!&BHHPJ@`?2G5Y=YDG]]OSH\R3^^WYTK#/4:*\N\R3^^WYT> M9)_?;\Z+`>HT5Y=YDG]]OSH\R3^^WYT6`Z#QG"!=6LN.60K^1_\`KUS.*D9F M;[Q)^II*8CI_!DF)+N+U"L/U_P`:ZVN+\('&J3#L82?_`!X5VE2QA7F-^/\` MB8W/_75_YFO3J\SO_P#D(7/_`%U;^9IH"KBO2-'_`.0-9_\`7)?Y5YS7H^C_ M`/('L_\`KDO\J&(NT444AG`^*!G7IO\`=7^0K&Q6WXG_`.0[-_NK_(5CU0CM MO"/&C-_UU;^0K>K"\)_\@=O^NK?R%;M2,*S]=_Y`EW_USK0K/US_`)`EW_N4 M`><8J]HX_P")S9_]=5_G52KND?\`(8L_^NJ_SJA'H]%%%2,****`"BBB@#G/ M%UEYUE'=J/FA.&/^R?\`Z^/SKB]M>I7$"7-M)`_W9%*G\:\TGA>WGDA<8=&* MG\*:$3:3=_8-4@G)PH;#_P"Z>#7I5>5XKT'0;S[9I$+$Y=!Y;?4?_6Q0QFG2 M,P12S'"@9)/84M8_B6\^RZ0Z*?GF/ECZ=_T_G2`XF_N6O;^>Y;_EHY('H.P_ M*JV*?5G3K0WNH0VX'#M\WL.I_2J$=GX:LOLFCQLPP\W[QOH>GZ8K8I``JA0, M`#`%+4C"BBB@`HHHH`****`"BBB@`HHHH`****`"BBF32K!"\KG"(I8GV%`' M*>+;SS+B*S4_+&-[_4]/T_G7-XJ>ZG:ZNI9W^](Q8^U14Q#<48K?A\*W;$F]0VULY&?PI__``B-W_S\0?K_`(47`YW%&*Z+_A$;O_GX@_7_``H_X1&[ M_P"?B#]?\*+@<[BC%=%_PB-W_P`_$'Z_X4?\(C=_\_$'Z_X47`YW%*I*L&4X M(.01VJ]J>ES:7,DA[_K5JN5\)WN'E MLF/!_>)]>A_I^5=54C"O+F7:Q7T.*]1KSC48O)U*YC_NRMCZ9IH"IBO2[)M] MA;N/XHE/Z5YM7?:!/Y^BVYSR@V'VQ_\`6Q0Q&E1112&%%%%`!1110`53U8$Z M1=@?\\F_E5RHKF/SK6:+^^C+^8H`\RQ0%).!R33L4J,8Y%<=5((JA#OLL_\` MSPD_[X-'V6?_`)X2?]\&O2HI%FB213\KJ&'T-/I7&>9?99_^>$G_`'P:/LL_ M_/"3_O@UZ;11<#S+[+/_`,\)/^^#1]EG_P">$G_?!KTVBBX'F7V6?_GA)_WP M:/LL_P#SPD_[X->FT47`Y;PI8S13374L;(I78NX8SSD_RKJ:**0!7FM\/^)A M<_\`75OYFO2J\VOO^0A<_P#75OYFF@*V*]%TC_D#VG_7)?Y5YY7H>D_\@BT_ MZY+_`"H8B[1112&<)XF'_$\F_P!U?Y"LC%;'B7_D-S?[J_R%9-,1VGA3_D#M M_P!=6_D*W*P_"O\`R"#_`-=6_D*W*0PJAK?_`"!;O_3?I/]XOU'_P!;-`'G^*Z+PG=^5>2V MK'Y95W+_`+P_^M_*N?J6UN&M;N*=.L;!OK[4Q'I=<5XIN_/U(0*>?IQ M@8_/`%KX13O9N<++\R9_O>GXC^5<]2JS(P920P.01V-4(]-HK"T MGQ%%<(L5XPBF'&\\*_\`@:W0<\CI4C"BBB@`HHK/N]:L+/(><,_]R/YC_P#6 MH`T**KV=Y#?6XG@)*$XY&"#5B@#SW5K4VFJ7$6,+NW+]#R*I8KK?%-@984O( MQEH_E?\`W>Q_`_SKDZ8CL/#.HB>T^QN?WL7W?=?_`*W^%;U>:P326TR31,5= M#D$5V&F^(K>Z54N2(9O<_*WT/:AC-JBD!!`(.0:6D`4444`%%4[G5+*T!\ZX M0,/X02S8;\!0!TE%%%`!7F]\/]/N?^NK?S->D5YQ> M_P#'_<_]=6_F::`KXKT/2?\`D$6G_7)?Y5Y[7H6D_P#()M/^N2_RH8BY1112 M&<-XD'_$[E_W5_D*R<5K^)/^0W+_`+J_R%9-4([/PM_R"#_UU;^0K;K$\+?\ M@D_]=6_D*VZD850UK_D#77^Y5^J>JQF72KI!U\MB/P&:`//,5T_ZZ MK_.JE26\I@N8I@,F-PP'T.:H1Z514<$T=Q`DT3!D<9!J2I&%%%-61')"NK$= M<'.*`'4444`%%%%`'GNJV?V'4IH0,)G^"*[4.%/NHH45RWA>R,MXUTP^2(87W8_\`UOYUUU#&%%%% M(`HHHH`****`"N;\5V>Z.*\4<5 MI:%>?8]4C+'"2?NV_'I^N*H2QO#*\4@*NIP0>QIM,1Z915/2[EKO3()G!W,N M#GN1QG]*N4AG'Z_HS6LK74"Y@"#WKG-1\,!V,MB M0I/)B8\?@:=P.6JS;W]W:C$%Q(@_N@\?E3+BUGM7V3Q/&?\`:'6HJ!&H/$6J M`8,X/UC7_"FOX@U-^/M.!_LHH_I6;10!-->W5QGSKB5QZ,Q(_*H*6M#3M(N; M^5,1LL.?FD(P,>WK0!U6@V_V?1X01\S_`+P_CT_3%:5(JA%"J,`#`%+2&(RJ MZE6`*D8(/<5Q&LZ.^G3&2,%K9C\I_N^QKN*:Z)(C(ZAE88((R#0!YI174:AX M7R3)8L!_TR<_R/\`C7/7%I<6K;9X7C/^T.#^-,007EU;?ZFXDC'HK''Y5;77 M]448%T?Q13_2LZB@#0;7M4?@W3?@JC^0JM-?7=)Q@'.T>E`& MQ1112&%>@Z8K)I=JK`@B)<@]N*&(MT444AG$>(_\`D-2_[J_R%9-:_B12-9D) M!`95(]^*R:8CLO"__()/_75OY"MJL;PPK+I&6!`:1B/<<5LTAA2$`@@C(/44 MM%`'GFHV;6-]+`P.`QJK7>:OI,>IPCD),GW'_H?:N+NK*XLI-EQ$R'L M>Q^AIW$.M-1N[$G[/,R`]5ZC\C5T^)-2*X$B`^H05DT4`69]2O;D$37,C`_P MYP/R%:OA2)VOYI03L6/!^I/'\C6#7;>'K)K33H';_/O0!K4444 MAA1110!#=VZW=I+`W1U(SZ'L:\Z=&CD9&&&4D$>A%>EUP_B%(TUF7RSU`+#T M./\`)IH#*I\4333)$@RSL%'U--K;\,VGGZB9V'RPKG_@1X']:!'6V\*VUO'" MGW44**DHHI#"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@".2"&8@RQ(Y' M3H-+10!2ETC M3YN7M(L_[(V_RJN?#NF$\0$?21O\:U:*`,Q?#^F+_P`NV3[NW^-6(]+L8N4M M(0?4H"?UJW10`@`4````=A2T44`%%%%`!44EM!*VZ2&-V]60$U+10!`+.U4@ MBVA!'0A!4]%%`!1110!')!%-CS8D?'37]X?QZ?I7):=:&]OXH!T8_,?0=Z]!`"@`#`'`H`6BBBD`4444`%%%%`!11 M10`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%% M`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444` M%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!6#XDU* M6T6*"WD*.^68KU`[?Y]JWJX77I7EUF?<"-A"J#Z`?Y/XT("Q:^)KV`!9@DZ^ MK<'\Q5F7Q;(R$16BHWJS[OTP*YRBG81)//+1CR34=%;6BZ(]Y(L]P MI6V!R`?X_P#ZU,#4\-:<8+